UK industry adopts cautious approach to MDA (Medical Devices Agency)/MCA (UK Medicines Control Agency) merger
This article was originally published in Clinica
Executive Summary
The UK medical devices industry was last week choosing its words carefully as it reacted to the news that the Medical Devices Agency and the Medicines Control Agency were to merge. A government announcement on June 13 said that the MDA and the MCA will merge in April 2003 in a move that is intended to meet the increasing technological convergence in these fields. The merger should also result in significant cost-savings.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.